Price target
21.390.000.00%
The 7 analysts offering 1 year price forecasts for 601607 have a max estimate of — and a min estimate of —.
Analyst rating
Based on 6 analysts giving stock ratings to 601607 in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
601607 EPS for the last quarter is 0.30 CNY despite the estimation of 0.27 CNY. In the next quarter EPS is expected to reach 0.22 CNY. Track more of SHANGHAI PHARMACEUTICALS HOLDING financials and stay on top of what is up with the company.
In the next quarter SHANGHAI PHARMACEUTICALS HOLDING revenue is expected to reach 70.73 B CNY. Check out SHANGHAI PHARMACEUTICALS HOLDING revenue and earnings and make informed decisions.
According to analysts, 601607 price target is 21.39 CNY with a max estimate of 24.90 CNY and a min estimate of 13.60 CNY. Check if this forecast comes true in a year, meanwhile watch SHANGHAI PHARMACEUTICALS HOLDING stock price chart and keep track of the current situation with 601607 news and stock market news.
We've gathered opinions of 6 analysts rating 601607 stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.